{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:33Z","timestamp":1792783413682,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271991"],"award-info":[{"award-number":["82271991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Anhui Province Key R&D Life and Health Category A Project","award":["2022e0702007"],"award-info":[{"award-number":["2022e0702007"]}]},{"name":"The Artificial Intelligence Joint Fund Innovation Project","award":["MAI2023C006"],"award-info":[{"award-number":["MAI2023C006"]}]},{"name":"The Anhui Province Academic Leaders Reserve Candidates Support A-level Projects","award":["2022H279"],"award-info":[{"award-number":["2022H279"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09718-2","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:52:33Z","timestamp":1762584753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lactylation-related multigene signature in multiple myeloma: integrated prognostic stratification, immune landscape profiling, and therapeutic guidance"],"prefix":"10.1007","volume":"73","author":[{"given":"Wuyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaibao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"9","key":"9718_CR1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99(9):1802\u201324.","journal-title":"Am J Hematol"},{"issue":"1","key":"9718_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, et al. Multiple myeloma. Nat Rev Dis Primers. 2024;10(1):45.","journal-title":"Nat Rev Dis Primers"},{"key":"9718_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116192","author":"CH Lin","year":"2024","unstructured":"Lin CH, et al. Current novel targeted therapeutic strategies in multiple myeloma. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116192.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"9718_CR4","first-page":"2420","volume":"109","author":"M Engelhardt","year":"2024","unstructured":"Engelhardt M, et al. Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible. Haematologica. 2024;109(8):2420\u201335.","journal-title":"Haematologica"},{"issue":"3","key":"9718_CR5","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9718_CR6","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9718_CR7","first-page":"e528","volume":"5","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for Diagnosis, treatment and Follow-up. Hemasphere. 2021;5(2):e528.","journal-title":"Hemasphere"},{"key":"9718_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16122263","author":"S Mor\u00e8","year":"2024","unstructured":"Mor\u00e8 S, et al. The challenging approach to multiple myeloma: from disease diagnosis and monitoring to complications management. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16122263.","journal-title":"Cancers (Basel)"},{"key":"9718_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajem.2024.11.073","volume":"88","author":"B Long","year":"2025","unstructured":"Long B, et al. An emergency medicine review: multiple myeloma and its complications. Am J Emerg Med. 2025;88:172\u20139.","journal-title":"Am J Emerg Med"},{"key":"9718_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"9718_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, et al. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5(1):25.","journal-title":"Mol Biomed"},{"issue":"23","key":"9718_CR12","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1182\/bloodadvances.2024014139","volume":"8","author":"MS Ebraheem","year":"2024","unstructured":"Ebraheem MS, et al. Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis. Blood Adv. 2024;8(23):5993\u20136002.","journal-title":"Blood Adv"},{"issue":"1","key":"9718_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22688-2","volume":"25","author":"H Zhang","year":"2025","unstructured":"Zhang H, et al. Time trends in multiple myeloma incidence and mortality across the BRICS from 1992 to 2021 and projection to 2046. BMC Public Health. 2025;25(1):1765.","journal-title":"BMC Public Health"},{"issue":"9","key":"9718_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e43325","volume":"11","author":"SE Mousavi","year":"2025","unstructured":"Mousavi SE, et al. Epidemiology, socioeconomic correlates, and trend projections of multiple myeloma in Asia over 2020\u20132040. Heliyon. 2025;11(9):e43325.","journal-title":"Heliyon"},{"issue":"1","key":"9718_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65937-x","volume":"14","author":"C Sun","year":"2024","unstructured":"Sun C, et al. Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification. Sci Rep. 2024;14(1):15142.","journal-title":"Sci Rep"},{"key":"9718_CR16","doi-asserted-by":"crossref","unstructured":"Frede J et al. The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma. Leukemia. 2025.","DOI":"10.1038\/s41375-025-02766-5"},{"key":"9718_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157301","author":"A Agafonova","year":"2025","unstructured":"Agafonova A, et al. Breaking barriers: the role of the bone marrow microenvironment in multiple myeloma progression. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26157301.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9718_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01280-2","volume":"15","author":"S Dingli","year":"2025","unstructured":"Dingli S, et al. The ratio of brain to liver glucose activity and disease activity in multiple myeloma. Blood Cancer J. 2025;15(1):90.","journal-title":"Blood Cancer J"},{"key":"9718_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100974","volume":"50","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. Targeting myeloma metabolism: how abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors. Neoplasia. 2024;50:100974.","journal-title":"Neoplasia"},{"key":"9718_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604143","volume":"10","author":"A Barbato","year":"2020","unstructured":"Barbato A, et al. Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: an overview. Front Oncol. 2020;10:604143.","journal-title":"Front Oncol"},{"issue":"1","key":"9718_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/brv.13135","volume":"100","author":"F Jing","year":"2025","unstructured":"Jing F, et al. Unlocking the multifaceted molecular functions and diverse disease implications of lactylation. Biol Rev Camb Philos Soc. 2025;100(1):172\u201389.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"1","key":"9718_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16(1):72.","journal-title":"Clin Epigenetics"},{"key":"9718_CR23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13456","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, et al. Potential of lactylation as a therapeutic target in cancer treatment (Review). Mol Med Rep. 2025. https:\/\/doi.org\/10.3892\/mmr.2025.13456.","journal-title":"Mol Med Rep"},{"key":"9718_CR24","volume":"8","author":"Q Li","year":"2025","unstructured":"Li Q, et al. Lactylation in tumor immune escape and immunotherapy: multifaceted functions and therapeutic strategies. Research. 2025;8:p0793.","journal-title":"Research"},{"issue":"11","key":"9718_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li H, et al. Lactylation in cancer: current understanding and challenges. Cancer Cell. 2024;42(11):1803\u20137.","journal-title":"Cancer Cell"},{"issue":"8","key":"9718_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","volume":"35","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zheng Y, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol Metab. 2024;35(8):720\u201331.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"9718_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"9718_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70045","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, et al. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin Transl Med. 2024;14(10):e70045.","journal-title":"Clin Transl Med"},{"issue":"21","key":"9718_CR29","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. H3k18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 2024;84(21):3589\u2013601.","journal-title":"Cancer Res"},{"issue":"1","key":"9718_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193.","journal-title":"Cell Death Dis"},{"issue":"46","key":"9718_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci. 2024;11(46):e2401399.","journal-title":"Adv Sci"},{"key":"9718_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1535611","volume":"13","author":"P Shi","year":"2025","unstructured":"Shi P, Ma Y, Zhang S. Non-histone lactylation: unveiling its functional significance. Front Cell Dev Biol. 2025;13:1535611.","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"9718_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33554","volume":"10","author":"W Kong","year":"2024","unstructured":"Kong W, et al. Histone lactylation-related genes correlate with the molecular patterns and functions of cancer-associated fibroblasts and have significant clinical implications in clear cell renal cell carcinoma. Heliyon. 2024;10(13):e33554.","journal-title":"Heliyon"},{"issue":"1","key":"9718_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03592-y","volume":"24","author":"M Gao","year":"2024","unstructured":"Gao M, et al. Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma. Cancer Cell Int. 2024;24(1):400.","journal-title":"Cancer Cell Int"},{"key":"9718_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, et al. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"9718_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"5","key":"9718_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij O, et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020;1(5):493\u2013506.","journal-title":"Nat Cancer"},{"issue":"1","key":"9718_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06167-1","volume":"23","author":"Q An","year":"2025","unstructured":"An Q, et al. Role of CD4(+) T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment. J Transl Med. 2025;23(1):179.","journal-title":"J Transl Med"},{"issue":"8","key":"9718_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2174\/0118715206259585240105051941","volume":"24","author":"S Vishakha","year":"2024","unstructured":"Vishakha S, et al. An expedition on synthetic methodology of FDA-approved anticancer drugs (2018\u20132021). Anticancer Agents Med Chem. 2024;24(8):590\u2013626.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"9718_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2024025945","volume":"145","author":"S Sidana","year":"2025","unstructured":"Sidana S, et al. Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed\/refractory multiple myeloma. Blood. 2025;145(1):85\u201397.","journal-title":"Blood"},{"issue":"3","key":"9718_CR41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjh.17338","volume":"194","author":"L Rosi\u00f1ol","year":"2021","unstructured":"Rosi\u00f1ol L, et al. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol. 2021;194(3):496\u2013507.","journal-title":"Br J Haematol"},{"issue":"13","key":"9718_CR42","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-2830","volume":"10","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang H, Wang X. Palbociclib regulates the expression of dihydrofolate reductase and the cell cycle to inhibit t (11;14) multiple myeloma. Ann Transl Med. 2022;10(13):746.","journal-title":"Ann Transl Med"},{"key":"9718_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031456","author":"A Ferro","year":"2023","unstructured":"Ferro A, et al. Entinostat-bortezomib hybrids against multiple myeloma. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28031456.","journal-title":"Molecules"},{"issue":"11","key":"9718_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111126","volume":"14","author":"JC Boulos","year":"2021","unstructured":"Boulos JC, et al. Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells. Pharmaceuticals (Basel). 2021;14(11):1126.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"9718_CR45","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00622-9","volume":"23","author":"C Nanavati","year":"2021","unstructured":"Nanavati C, Mager DE. Network-based systems analysis explains sequence-dependent synergism of bortezomib and Vorinostat in multiple myeloma. AAPS J. 2021;23(5):101.","journal-title":"AAPS J"},{"issue":"1","key":"9718_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22(1):85.","journal-title":"Genome Biol"},{"issue":"1","key":"9718_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2304161","volume":"25","author":"F Yan","year":"2024","unstructured":"Yan F, et al. Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer Biol Ther. 2024;25(1):2304161.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"9718_CR48","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377.","journal-title":"JAMA"},{"issue":"9","key":"9718_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00527-y","volume":"11","author":"R Bansal","year":"2021","unstructured":"Bansal R, Rakshit S, Kumar S. Extramedullary disease in multiple myeloma. Blood Cancer J. 2021;11(9):161.","journal-title":"Blood Cancer J"},{"issue":"1","key":"9718_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13045-025-01675-5","volume":"18","author":"H Zheng","year":"2025","unstructured":"Zheng H. BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting. J Hematol Oncol. 2025;18(1):23.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"9718_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/oncolo\/oyad306","volume":"29","author":"A Rafae","year":"2024","unstructured":"Rafae A, van Rhee F, Al S, Hadidi. Perspectives on the treatment of multiple myeloma. Oncologist. 2024;29(3):200\u201312.","journal-title":"Oncologist"},{"issue":"7774","key":"9718_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-019-1553-0","volume":"573","author":"RD Luteijn","year":"2019","unstructured":"Luteijn RD, et al. SLC19A1 transports immunoreactive Cyclic dinucleotides. Nature. 2019;573(7774):434\u20138.","journal-title":"Nature"},{"key":"9718_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030571","author":"Y Pan","year":"2025","unstructured":"Pan Y, Liu Z, Wu C. Pan-cancer characterization identifies SLC19A1 as an unfavorable prognostic marker and associates it with tumor infiltration features. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13030571.","journal-title":"Biomedicines"},{"key":"9718_CR54","first-page":"492","volume":"21","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer. Mol Ther. 2021;21:492\u2013506.","journal-title":"Mol Ther"},{"key":"9718_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122490","volume":"341","author":"T Wang","year":"2024","unstructured":"Wang T, et al. Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma. Life Sci. 2024;341:122490.","journal-title":"Life Sci"},{"issue":"1","key":"9718_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41(1):345.","journal-title":"J Exp Clin Cancer Res"},{"issue":"19","key":"9718_CR57","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3748\/wjg.v30.i19.2575","volume":"30","author":"T Peng","year":"2024","unstructured":"Peng T, et al. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. World J Gastroenterol. 2024;30(19):2575\u2013602.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"9718_CR58","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.7150\/jca.51565","volume":"12","author":"Z Ji","year":"2021","unstructured":"Ji Z, et al. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer. J Cancer. 2021;12(7):2030\u201340.","journal-title":"J Cancer"},{"issue":"44","key":"9718_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4920","volume":"8","author":"L Uusk\u00fcla-Reimand","year":"2022","unstructured":"Uusk\u00fcla-Reimand L, Wilson MD. Untangling the roles of TOP2A and TOP2B in transcription and cancer. Sci Adv. 2022;8(44):eadd4920.","journal-title":"Sci Adv"},{"issue":"23","key":"9718_CR60","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.7150\/jca.26698","volume":"9","author":"H Xiao","year":"2018","unstructured":"Xiao H, et al. Identification of five genes as a potential biomarker for predicting progress and prognosis in adrenocortical carcinoma. J Cancer. 2018;9(23):4484\u201395.","journal-title":"J Cancer"},{"issue":"1","key":"9718_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01295-4","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng X, et al. Expression and biological significance of topoisomerase II \u03b1 (TOP2A) in oral squamous cell carcinoma. Discov Oncol. 2024;15(1):423.","journal-title":"Discov Oncol"},{"key":"9718_CR62","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260227","author":"JS Park","year":"2022","unstructured":"Park JS, et al. Interaction between VPS13A and the XK scramblase is important for VPS13A function in humans. J Cell Sci. 2022. https:\/\/doi.org\/10.1242\/jcs.260227.","journal-title":"J Cell Sci"},{"key":"9718_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1448764","volume":"15","author":"G Gao","year":"2024","unstructured":"Gao G, et al. Mitochondria-associated programmed cell death: elucidating prognostic biomarkers, immune checkpoints, and therapeutic avenues in multiple myeloma. Front Immunol. 2024;15:1448764.","journal-title":"Front Immunol"},{"issue":"2","key":"9718_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3892\/ijo.2014.2773","volume":"46","author":"S Moriya","year":"2015","unstructured":"Moriya S, et al. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress\u2013mediated cell death in multiple myeloma cells. Int J Oncol. 2015;46(2):474\u201386.","journal-title":"Int J Oncol"},{"issue":"8","key":"9718_CR65","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3324\/haematol.2022.282399","volume":"108","author":"M Thomas","year":"2023","unstructured":"Thomas M, et al. PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant. Haematologica. 2023;108(8):2155\u201366.","journal-title":"Haematologica"},{"issue":"3","key":"9718_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clml.2021.09.015","volume":"22","author":"AD Nehlsen","year":"2022","unstructured":"Nehlsen AD, et al. The safety and efficacy of radiation therapy with concurrent dexamethasone, cyclophosphamide, etoposide, and cisplatin-based systemic therapy for multiple myeloma. Clin Lymphoma Myeloma Leuk. 2022;22(3):192\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"9718_CR67","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00044-025-03411-7","volume":"34","author":"Shagufta","year":"2025","unstructured":"Shagufta, et al. Pharmacological significance of Palbociclib and its derivatives in cancer treatment and prevention: an update. Med Chem Res. 2025;34(6):1237\u201352.","journal-title":"Med Chem Res"},{"issue":"7","key":"9718_CR68","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1021\/acschembio.5c00270","volume":"20","author":"X Guo","year":"2025","unstructured":"Guo X, et al. Quantitative proteomics reveals the role of lysine lactylation in Lenalidomide-resistance in multiple myeloma cells. ACS Chem Biol. 2025;20(7):1728\u201338.","journal-title":"ACS Chem Biol"},{"issue":"1","key":"9718_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02524-0","volume":"16","author":"Y Yin","year":"2025","unstructured":"Yin Y, Luo M. Lactylation-related risk model for prognostication and therapeutic responsiveness in uterine corpus endometrial carcinoma. Discov Oncol. 2025;16(1):677.","journal-title":"Discov Oncol"},{"key":"9718_CR70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molimm.2022.12.015","volume":"154","author":"Y-T Zhang","year":"2023","unstructured":"Zhang Y-T, et al. Effects of lactate on metabolism and differentiation of CD4\u2009+\u2009T cells. Mol Immunol. 2023;154:96\u2013107.","journal-title":"Mol Immunol"},{"key":"9718_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1549724","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, et al. A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma. Front Oncol. 2025;15:1549724.","journal-title":"Front Oncol"},{"issue":"4","key":"9718_CR72","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s42255-025-01259-0","volume":"7","author":"H Ren","year":"2025","unstructured":"Ren H, Tang Y, Zhang D. The emerging role of protein L-lactylation in metabolic regulation and cell signalling. Nat Metab. 2025;7(4):647\u201364.","journal-title":"Nat Metab"},{"issue":"11","key":"9718_CR73","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri D, et al. Histone lactylation drives CD8(+) T cell metabolism and function. Nat Immunol. 2024;25(11):2140\u201351.","journal-title":"Nat Immunol"},{"issue":"42","key":"9718_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh4655","volume":"9","author":"W Fan","year":"2023","unstructured":"Fan W, et al. Global lactylome reveals lactylation-dependent mechanisms underlying T(H)17 differentiation in experimental autoimmune uveitis. Sci Adv. 2023;9(42):eadh4655.","journal-title":"Sci Adv"},{"key":"9718_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.688910","volume":"12","author":"AN Chen","year":"2021","unstructured":"Chen AN, et al. Lactylation, a novel metabolic reprogramming code: current status and prospects. Front Immunol. 2021;12:688910.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09718-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:03:29Z","timestamp":1770192209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09718-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}